Clinical Trials Search Tool

Double-blind, Placebo-controlled and Long-term Study Evaluating the Efficacy and Safety of Prucalopride in Pediatric Subjects with Functional Constipation

Disease/Condition: Functional Constipation

Location: Gresham

Ages: 6 months – 17 years

Enrollment Opens: 07-07-2021

Enrollment Closes: TBD


Phase 3, Multicenter, Randomized Study with 2 Different Doses of Prucalopride Administered to Male and Female Pediatric Subjects Aged 6 Months to 17 years with Functional Constipation, Consisting of a 12-week Double-blind, Placebo-controlled Part (Part A) to Evaluate Efficacy and Safety Followed by a 36-week Double-blind Extension Part (Part B) to Document Long-term Safety up to Week 48

Study ID: TAK-555-3010

To Enroll: Contact Cyn3rgy Research at; 503-907-2179 ext. 4 or visit us on the web at

Posted by: Cyn3rgy Research |